ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 212

$593K Total Retail Price of All Prescriptions

Rank: 13 out of 212

266 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 266 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 266 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,185 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LEVOTHYROXINE SODIUM 287 217 1 7
HYDROCODONE-ACETAMINOPHEN 280 149 S3 2 10
PRAVASTATIN SODIUM 279 256 3 15
SIMVASTATIN 273 233 4 1
METOPROLOL SUCCINATE 236 201 5 14
OMEPRAZOLE 227 184 6 9
FUROSEMIDE 211 177 7 11
ALLOPURINOL 160 131 8 18
METFORMIN HCL 153 127 9 5
AMLODIPINE BESYLATE 148 139 10 3
ATORVASTATIN CALCIUM 146 124 11 6
POTASSIUM CHLORIDE 135 102 12 27
CARVEDILOL 129 117 13 23
LOSARTAN POTASSIUM 119 103 14 4
RANITIDINE HCL 115 108 15 29
MORPHINE SULFATE ER 111 43 S2 16 57
PANTOPRAZOLE SODIUM 107 96 17 44
OXYCODONE HCL 107 23 S2 17 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 95 19 24
LOSARTAN-HYDROCHLOROTHIAZIDE 88 81 20 20
ISOSORBIDE MONONITRATE ER 88 69 20 78
LISINOPRIL 79 64 22 2
HYDRALAZINE HCL 72 65 23 93
WARFARIN SODIUM 72 56 23 19
TRAZODONE HCL 71 19 25 52
ZOLPIDEM TARTRATE 71 37 25 26
TAMSULOSIN HCL 70 67 27 21
HYDROCHLOROTHIAZIDE 69 61 28 8
GLIPIZIDE 68 68 29 38
LOVASTATIN 66 45 30 12
NIFEDIPINE ER 64 53 31 77
DIGOXIN 64 51 31 41
DOXYCYCLINE HYCLATE 63 41 33 90
AMLODIPINE BESYLATE-BENAZEPRIL 63 40 33 30
ALENDRONATE SODIUM 63 52 33 16
ULORIC 62 43 36 182
PLAVIX 62 60 36 54
CLOPIDOGREL 61 61 38 31
PREDNISONE 59 45 39 46
GABAPENTIN 59 40 39 22
ATENOLOL 58 43 41 13
LACTULOSE 58 32 41 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 44 43 110
FLUTICASONE PROPIONATE 55 46 44 48
HYDROXYZINE HCL 55 35 R 44 113
AZITHROMYCIN 55 41 44 40
SPIRIVA 54 49 47 45
PRANDIN 53 30 48 135
TRAMADOL HCL 53 42 48 50
BACLOFEN 52 23 50 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.